Simulating pharmacokinetic and pharmacodynamic fuzzy-parameterized models: a comparison of numerical methods
- PMID: 17710517
- DOI: 10.1007/s10928-007-9061-5
Simulating pharmacokinetic and pharmacodynamic fuzzy-parameterized models: a comparison of numerical methods
Abstract
Statistical techniques have been traditionally used to deal with parametric variation in pharmacokinetic and pharmacodynamic models, but these require substantial data for estimates of probability distributions. In the presence of limited, inaccurate or imprecise information, simulation with fuzzy numbers represents an alternative tool to handle parametric uncertainty. Existing methods for implementing fuzzy arithmetic may, however, have significant shortcomings in overestimating (e.g., conventional fuzzy arithmetic) and underestimating (e.g., vertex method) the output uncertainty. The purpose of the present study is to apply and compare the applicability of conventional fuzzy arithmetic, vertex method and two recently proposed numerical schemes, namely transformation and optimization methods, for uncertainty modeling in pharmacokinetic and pharmacodynamic fuzzy-parameterized systems. A series of test problems were examined, including empirical pharmacokinetic and pharmacodynamic models, a function non-monotonic in its parameters, and a whole body physiologically based pharmacokinetic model. Our results verified that conventional fuzzy arithmetic can lead to overestimation of response uncertainty and should be avoided. For the monotonic pharmacokinetic and pharmacodynamic models, the vertex method accurately predicted fuzzy-valued output while incurring the least computational cost. It turned out that the choice of a suitable method for fuzzy simulation of the non-monotonic function depended on the required accuracy of the results: the vertex method was capable of eliciting an initial approximate solution with few function evaluations; for more accurate results, the transformation method was the most superior approach in terms of accuracy per unit CPU time.
Similar articles
-
A fuzzy physiologically based pharmacokinetic modeling framework to predict drug disposition in humans.Conf Proc IEEE Eng Med Biol Soc. 2006;Suppl:6485-8. doi: 10.1109/IEMBS.2006.260879. Conf Proc IEEE Eng Med Biol Soc. 2006. PMID: 17959432
-
A fuzzy physiologically based pharmacokinetic modeling framework to predict drug disposition in humans.Conf Proc IEEE Eng Med Biol Soc. 2006;2006:5037-40. doi: 10.1109/IEMBS.2006.259383. Conf Proc IEEE Eng Med Biol Soc. 2006. PMID: 17947127
-
Fuzzy simulation of pharmacokinetic models: case study of whole body physiologically based model of diazepam.J Pharmacokinet Pharmacodyn. 2004 Jun;31(3):185-213. doi: 10.1023/b:jopa.0000039564.35602.78. J Pharmacokinet Pharmacodyn. 2004. PMID: 15518244
-
Fuzzy pharmacology: theory and applications.Trends Pharmacol Sci. 2002 Sep;23(9):412-7. doi: 10.1016/s0165-6147(02)02055-2. Trends Pharmacol Sci. 2002. PMID: 12237153 Review.
-
Methodological issues in pharmacokinetic-pharmacodynamic modelling.Clin Pharmacokinet. 1998 Aug;35(2):151-66. doi: 10.2165/00003088-199835020-00004. Clin Pharmacokinet. 1998. PMID: 9739481 Review.
Cited by
-
Physiologically based pharmacokinetic modeling of drug disposition in rat and human: a fuzzy arithmetic approach.Pharm Res. 2008 Aug;25(8):1771-81. doi: 10.1007/s11095-007-9447-5. Epub 2008 Mar 25. Pharm Res. 2008. PMID: 18363078
-
The Application of a Physiologically Based Toxicokinetic Model in Health Risk Assessment.Toxics. 2023 Oct 21;11(10):874. doi: 10.3390/toxics11100874. Toxics. 2023. PMID: 37888724 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources